329 related articles for article (PubMed ID: 31301327)
1. Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.
Margolis EB; Karkhanis AN
Neurochem Int; 2019 Oct; 129():104504. PubMed ID: 31301327
[TBL] [Abstract][Full Text] [Related]
2. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
3. Learned avoidance requires VTA KOR-mediated reductions in dopamine.
Robble MA; Bozsik ME; Wheeler DS; Wheeler RA
Neuropharmacology; 2020 May; 167():107996. PubMed ID: 32057802
[TBL] [Abstract][Full Text] [Related]
4. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.
Chefer VI; Bäckman CM; Gigante ED; Shippenberg TS
Neuropsychopharmacology; 2013 Dec; 38(13):2623-31. PubMed ID: 23921954
[TBL] [Abstract][Full Text] [Related]
5. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
Schindler AG; Messinger DI; Smith JS; Shankar H; Gustin RM; Schattauer SS; Lemos JC; Chavkin NW; Hagan CE; Neumaier JF; Chavkin C
J Neurosci; 2012 Dec; 32(49):17582-96. PubMed ID: 23223282
[TBL] [Abstract][Full Text] [Related]
6. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
[TBL] [Abstract][Full Text] [Related]
7. Ventral pallidal modulation of aversion processing.
Wulff AB; Tooley J; Marconi LJ; Creed MC
Brain Res; 2019 Jun; 1713():62-69. PubMed ID: 30300634
[TBL] [Abstract][Full Text] [Related]
8. Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis.
Pirino BE; Spodnick MB; Gargiulo AT; Curtis GR; Barson JR; Karkhanis AN
Neuropharmacology; 2020 Dec; 181():108341. PubMed ID: 33011200
[TBL] [Abstract][Full Text] [Related]
9. Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.
Chartoff EH; Ebner SR; Sparrow A; Potter D; Baker PM; Ragozzino ME; Roitman MF
Neuropsychopharmacology; 2016 Mar; 41(4):989-1002. PubMed ID: 26239494
[TBL] [Abstract][Full Text] [Related]
10. Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy.
Meade JA; Alkhlaif Y; Contreras KM; Obeng S; Toma W; Sim-Selley LJ; Selley DE; Damaj MI
Psychopharmacology (Berl); 2020 Sep; 237(9):2777-2793. PubMed ID: 32529265
[TBL] [Abstract][Full Text] [Related]
11. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
Gross JD; Kaski SW; Schmidt KT; Cogan ES; Boyt KM; Wix K; Schroer AB; McElligott ZA; Siderovski DP; Setola V
Neuropsychopharmacology; 2019 Sep; 44(10):1728-1741. PubMed ID: 31141817
[TBL] [Abstract][Full Text] [Related]
12. Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions.
Wu M; Minkowicz S; Dumrongprechachan V; Hamilton P; Xiao L; Kozorovitskiy Y
Elife; 2021 Apr; 10():. PubMed ID: 33904412
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
14. Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.
Abraham AD; Casello SM; Land BB; Chavkin C
Addict Neurosci; 2022 Mar; 1():. PubMed ID: 36176476
[TBL] [Abstract][Full Text] [Related]
15. Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
Karkhanis A; Holleran KM; Jones SR
Int Rev Neurobiol; 2017; 136():53-88. PubMed ID: 29056156
[TBL] [Abstract][Full Text] [Related]
16. The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors.
Fortin SM; Chartoff EH; Roitman MF
Neuropsychopharmacology; 2016 Feb; 41(3):906-15. PubMed ID: 26211731
[TBL] [Abstract][Full Text] [Related]
17. Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain.
Vergara F; Sardi NF; Pescador AC; Guaita GO; Jark Stern CA; Chichorro JG; Fischer L
Neuropharmacology; 2020 Nov; 178():108226. PubMed ID: 32771527
[TBL] [Abstract][Full Text] [Related]
18. Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders.
Tejeda HA; Bonci A
Brain Res; 2019 Jun; 1713():91-101. PubMed ID: 30244022
[TBL] [Abstract][Full Text] [Related]
19. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
Abraham AD; Fontaine HM; Song AJ; Andrews MM; Baird MA; Kieffer BL; Land BB; Chavkin C
Neuropsychopharmacology; 2018 Jan; 43(2):362-372. PubMed ID: 28649993
[TBL] [Abstract][Full Text] [Related]
20. The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.
Laman-Maharg AR; Copeland T; Sanchez EO; Campi KL; Trainor BC
Behav Brain Res; 2017 Aug; 332():299-307. PubMed ID: 28625549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
